Providing Diagnostic Pathology Services in Low and Middle-Income Countries

Deo Ruhangaza; Linda S Kennedy; Gregory J Tsongalis

doi:10.1016/j.hoc.2023.05.015

Providing Diagnostic Pathology Services in Low and Middle-Income Countries

Hematol Oncol Clin North Am. 2024 Feb;38(1):209-216. doi: 10.1016/j.hoc.2023.05.015. Epub 2023 Jun 14.

Authors

Deo Ruhangaza¹, Linda S Kennedy², Gregory J Tsongalis³

Affiliations

¹ Department of Pathology, Butaro Hospital and University of Global Health Equity, Rwanda.
² Strategic Initiatives & Global Oncology at the Dartmouth Cancer Center, Dartmouth Health, Lebanon, NH, USA.
³ Pathology and Laboratory Medicine, Dartmouth Health and the Dartmouth Cancer Center, Lebanon, NH, USA; Geisel School of Medicine, Hanover, NH, USA. Electronic address: [email protected].

PMID: 37328312
DOI: 10.1016/j.hoc.2023.05.015

Abstract

Diagnostic pathology services in low and middle-income countries are often hindered by lack of expertise, equipment, and reagents. However, there are also educational, cultural, and political decisions, which must be addressed in order to provide these services successfully. In this review, we describe some of the infrastructure barriers that must be overcome and provide 3 examples of implementing molecular testing in Rwanda and Honduras despite initial lack of resources.

Keywords: Breast cancer; CML; Cervical cancer; Diagnostic pathology; LMICs.

Publication types

Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Clinical Laboratory Services*
Developing Countries*
Humans

Grants and funding

P30 CA023108/CA/NCI NIH HHS/United States